Therefore, the persistent activation of STAT3 in cancer cells in vivo is likely a result of the combined action of IL-6 class cytokines that function in a paracrine and in an autocrine manner as shown by Fukuda et al. [71]. This evidence concerns the gene STAT3 and cancer.